Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SPRB | US
0.05
11.11%
Healthcare
Biotechnology
30/06/2024
16/10/2024
0.52
0.46
0.54
0.46
Spruce Biosciences Inc. a biopharmaceutical company focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont a non-steroidal therapy to enhance disease control and reduce steroid burden for patients suffering from congenital adrenal hyperplasia (CAH) which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovary syndrome which is in Phase 2 clinical trial. The company has a license agreement with Eli Lilly and Company to research develop and commercialize compounds for various pharmaceutical uses; and collaboration and license agreement with Kaken Pharmaceutical Co. Ltd. to develop manufacture and commercialize tildacerfont for the treatment of CAH in Japan. Spruce Biosciences Inc. was incorporated in 2014 and is headquartered in South San Francisco California.
View LessStrength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
70.9%1 month
60.6%3 months
50.0%6 months
52.4%-
-
0.31
0.06
0.05
-0.23
15.32
-
-47.43M
21.44M
21.44M
-
-623.35
-
-25.60
-55.37
0.88
0.92
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.12
Range1M
0.12
Range3M
0.18
Rel. volume
2.63
Price X volume
721.13K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Iterum Therapeutics plc | ITRM | Biotechnology | 1.03 | 23.38M | 0.98% | n/a | -198.11% |
ImmunoCellular Therapeutics Ltd | IMUC | Biotechnology | 0.138 | 23.09M | 17.95% | 0.02 | -82.78% |
HCW Biologics Inc. Common Stock | HCWB | Biotechnology | 0.6 | 22.69M | 3.45% | n/a | -159.13% |
Cyclo Therapeutics Inc | CYTH | Biotechnology | 0.79 | 22.67M | 5.33% | n/a | -58.50% |
Cocrystal Pharma Inc | COCP | Biotechnology | 2.2 | 22.38M | 20.05% | n/a | 10.24% |
Tonix Pharmaceuticals Holding Corp | TNXP | Biotechnology | 0.159 | 22.26M | 12.77% | n/a | 21.99% |
BIOR | BIOR | Biotechnology | 0.59 | 21.52M | 6.61% | n/a | -52.57% |
Pieris Pharmaceuticals Inc | PIRS | Biotechnology | 16.49 | 21.51M | 1.48% | n/a | 0.00% |
Matinas BioPharma Holdings Inc | MTNB | Biotechnology | 3.89 | 19.70M | 11.78% | n/a | 16.97% |
NeuroSense Therapeutics Ltd. Ordinary Shares | NRSN | Biotechnology | 0.9795 | 19.40M | 2.35% | n/a | -2.11% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 12.5 | 19.04M | 4.17% | n/a | 204.46% |
ILAG | ILAG | Building Products & Equipment | 1.02 | 18.42M | 2.01% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.6542 | 9.49M | -5.19% | 0.04 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2051 | 3.68M | -6.82% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.09 | 2.84M | -0.91% | n/a | 9.62% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 897.66K | -0.99% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.42 | 0 | 2.63% | n/a | |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 4.21 | 0 | 3.19% | n/a | |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.5 | 0 | 1.42% | n/a | |
Urban One Inc | UONEK | Broadcasting - Radio | 1.05 | 0 | 6.06% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.23 | 0.53 | Cheaper |
Ent. to Revenue | 15.32 | 4,005.99 | Cheaper |
PE Ratio | - | 40.42 | - |
Price to Book | 0.31 | 15.30 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 49.97 | 72.92 | Lower Risk |
Debt to Equity | 0.06 | -1.24 | Expensive |
Debt to Assets | 0.05 | 0.25 | Cheaper |
Market Cap | 21.44M | 3.78B | Emerging |